EMEA-000093-PIP01-07-M01
Key facts
Active substance |
Sotrastaurin acetate
|
Therapeutic area |
Immunology-Rheumatology-Transplantation
|
Decision number |
P/155/2011
|
PIP number |
EMEA-000093-PIP01-07-M01
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Treatment of chronic plaque psoriasis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Novartis Europharm Ltd
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|